June 1, 2023, 11:28 a.m. | Carly Page

TechCrunch techcrunch.com

Enzo Biochem, a New York-based biotechnology company, has confirmed that a ransomware attack exposed the clinical test information of almost 2.5 million patients. Enzo, which manufactures and sells DNA-based tests to detect viral and bacterial diseases including COVID-19 and cancer, confirmed in an SEC filing this week that it experienced a ransomware attack on April […]


Enzo Biochem says ransomware attack exposed clinical test data of 2.5 million patients by Carly Page originally published on TechCrunch

attack cancer covid cybersecurity data data breach detect dna enzo exposed filing information new york patients ransomware ransomware attack sec security test tests viral

SOC 2 Manager, Audit and Certification

@ Deloitte | US and CA Multiple Locations

Lead Technical Product Manager - Threat Protection

@ Mastercard | Remote - United Kingdom

Data Privacy Officer

@ Banco Popular | San Juan, PR

GRC Security Program Manager

@ Meta | Bellevue, WA | Menlo Park, CA | Washington, DC | New York City

Cyber Security Engineer

@ ASSYSTEM | Warrington, United Kingdom

Privacy Engineer, Technical Audit

@ Meta | Menlo Park, CA